Physician profile
Christopher Helak
NPI 1275820987
$9,094.07
in general payments reported to CMS, 2019-2025
24 companies · $1,629 in 2025
The $1,629 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,137 · 2020: $483 · 2021: $335 · 2022: $852 · 2023: $77.34 · 2024: $580 · 2025: $1,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,531 · Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,530.53 |
| Food and Beverage | $756.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,458.37 | 2019-2024 | |
| Medtronic, INC. | $2,290.84 | 2022-2025 | Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology, Pivox Oblique Lateral Spinal System |
| Novo Nordisk INC | $299.15 | 2019-2024 | Wegovy |
| W. L. Gore & Associates, INC. | $215.63 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $190.01 | 2019-2025 | Spyglass Discover |
| Allergan, INC. | $100.73 | 2019-2022 | |
| Ethicon US, LLC | $90.35 | 2019-2022 | |
| Smith+Nephew, INC. | $80.42 | 2020-2021 | |
| Trevena, INC. | $61.25 | 2022 | |
| Paratek Pharmaceuticals, INC. | $52.01 | 2021 | |
| Convatec INC. | $25.88 | 2024 | |
| Organogenesis INC. | $25.21 | 2023 | Puraply |
| Cook Medical LLC | $24.34 | 2020-2021 | |
| Integra Lifesciences Corporation | $22.41 | 2019 | |
| Davol INC. | $21.30 | 2023 | Arista Ah Flexitip |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $17.55 | 2019 | |
| Daiichi Sankyo INC. | $17.06 | 2023 | Injectafer |
| Abbvie INC. | $15.99 | 2021 | |
| Aroa Biosurgery Incorporated | $15.08 | 2019-2020 | |
| Olympus America INC. | $14.74 | 2019 | |
| Teleflex LLC | $14.29 | 2020 | |
| Polarityte, INC. | $14.29 | 2020 | |
| Endogastric Solutions, INC | $13.87 | 2022 | |
| Lilly USA, LLC | $13.30 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Helak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.